VI.6 Detection of DNA adducts in the human endometrium: A lack of evidence

European Journal of Cancer

Volumn 34, Issue SUPPL. 4, 1998, Pages

  Carmichael, P L ^a   Sardar, S ^a   Neven, P ^b   Van Hoof, I ^b   Ugwumadu, A ^c   Bourne, T ^c   Tomas E ^d   Hellberg, P ^e   Hewer, A J ^f   Phillips, D H ^f  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b Saint Jean Clinic of Brussels   (Belgium)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DNA; NUCLEASE; PHOSPHODIESTERASE; PHOSPHORUS 32; TAMOXIFEN; TOREMIFENE;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA ADDUCT; ENDOMETRIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MULTICENTER STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; THIN LAYER CHROMATOGRAPHY;

EID: 0031719521     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00124-5     Document Type: Conference Paper

References (2)

1. Carmichael PL, Ugwumadu AHN, Neven P, Hewer AJ, Poon GK, Phillips DH. Lack of genotoxicity of tamoxifen in human endometrium. Cancer Res 1996, 56, 1475-1479.
2. Hemminki K, Ranjaniemi H, Lindahl B, Moberger B. Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients. Cancer Res 1996, 56, 4374-4377.